Evidence map›Paper›PMID 23978192›Full record

Trial reportCOPD2013

Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations.

Victor Kim, Alice L Sternberg, George Washko, Barry J Make, Meilan K Han, Fernando Martinez, Gerard J Criner, National Emphysema Treatment Trial Research Group

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in COPD, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. The European respiratory journal · 2022
    Pooled it
  2. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.International journal of chronic obstructive pulmonary disease · 2017
    Trial
  3. Exploring Relevance of Graded Sputum Production in Stable COPD in Clinical Practice.International journal of chronic obstructive pulmonary disease · 2026
    Article
  4. Observational
  5. Article
  6. Chronic Bronchitis: Where Are We Now?Chronic obstructive pulmonary diseases (Miami, Fla.) · 2019
    Article
  7. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.International journal of chronic obstructive pulmonary disease · 2019
    Article
  8. Article
  9. Alternative definitions of chronic bronchitis and their correlation with CT parameters.International journal of chronic obstructive pulmonary disease · 2018
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Observational
  19. Preventing COPD exacerbations: new options for a crucial and growing problem.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Victor Kim1Temple University School of Medicine , Philadelphia, PA , USA.
Alice L Sternberg
George Washko
Barry J Make
Meilan K Han
Fernando Martinez
Gerard J Criner
National Emphysema Treatment Trial Research Group
Temple University · USUniversity of Michigan · USBrigham and Women's Hospital · USJohns Hopkins University · USNational Jewish Health · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
CLINICAL COORDINATING CENTER FOR LVRS-N01HR76119-268076119-268076119N01HR076119 · HR · JOHNS HOPKINS UNIVERSITY · PI PIANTADOSI, STEVEN · 1997 to 2006
$871k
Th17 inflammation is responsible for mucous metaplasia in COPDK23HL094696 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KIM, VICTOR · 2011 to 2014
$563k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076118 · HR · UNIVERSITY OF WASHINGTON · PI ALBERT, RICHARD K · 1997 to 2000
$225k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076113 · HR · UNIVERSITY OF PENNSYLVANIA · PI KAISER, LARRY · 1997 to 2000
$208k
CLNICAL CENTER FOR LVRSN01HR076104 · HR · CEDARS-SINAI MEDICAL CENTER · PI MCKENNA, RICHARD · 1997 to 2000
$153k
CLNICAL CENTER FOR THE LVRSN01HR076102 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI REILLY, JOHN J · 1997 to 2000
$150k
CLINICAL CENTER FOR LVRSN01HR076114 · HR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KEENAN, ROBERT J · 1997 to 2000
$147k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076110 · HR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FERNANDO, MARTINEZ J · 1997 to 2000
$146k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076111 · HR · NATIONAL JEWISH HEALTH · PI CHERNIACK, REUBEN M · 1997 to 2000
$144k
CLINICAL CENTER FOR THE LUNG VOLUME REDUCTION SURGERYN01HR076106 · HR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBURG, MARK E · 1997 to 2000
$143k
CLINICAL CENTER FOR THE LUNG VOLUME REDUCTION SURGERYN01HR076103 · HR · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI RIES, ANDREW L · 1997 to 2000
$142k
NCRR NIH HHS M01 RR000051NHLBI NIH HHS K23 HL094696NHLBI NIH HHS K23HL094696-03NHLBI NIH HHS N01HR76101NHLBI NIH HHS N01HR76102NHLBI NIH HHS N01HR76103NHLBI NIH HHS N01HR76104NHLBI NIH HHS N01HR76105NHLBI NIH HHS N01HR76106NHLBI NIH HHS N01HR76107NHLBI NIH HHS N01HR76108NHLBI NIH HHS N01HR76109NHLBI NIH HHS N01HR76110NHLBI NIH HHS N01HR76111NHLBI NIH HHS N01HR76112NHLBI NIH HHS N01HR76113NHLBI NIH HHS N01HR76114NHLBI NIH HHS N01HR76115NHLBI NIH HHS N01HR76116NHLBI NIH HHS N01HR76118NHLBI NIH HHS N01HR76119
6 · The paper itself

Abstract

backgroundChronic bronchitis in COPD has been associated with an increased exacerbation rate, more hospitalizations, and an accelerated decline in lung function. The clinical characteristics of patients with advanced emphysema and chronic bronchitis have not been well described.

methodsPatients randomized to medical therapy in the National Emphysema Treatment Trial were grouped based on their reports of cough and phlegm on the St. George's Respiratory Questionnaire(SGRQ) at baseline: chronic bronchitis(CB+) and no chronic bronchitis(CB-). The patients were similarly categorized into severe chronic bronchitis(SCB+) or no severe chronic bronchitis (SCB-) based on the above definition plus report of chest trouble. Kaplan-Meier survival analysis was used to determine the relationships between chronic bronchitis and severe chronic bronchitis and survival and time to hospitalization. Lung function and SGRQ scores over time were compared between groups.

resultsThe CB+(N = 234; 38%) and CB- groups(N = 376; 62%) had similar survival (median 60.8 versus 65.7 months, p = 0.19) and time to hospitalization (median 26.9 versus 24.9 months, p = 0.84). The SCB+ group(N = 74; 12%) had worse survival (median 47.7 versus 65.7 months, p = 0.02) and shorter time to hospitalization (median 18.5 versus 26.7 months, p = 0.02) than the SCB- group (N = 536; 88%). Mortality and hospitalization rates were not increased when chest trouble was analyzed by itself. The CB+ and CB-groups had similar lung function and SGRQ scores over time. The SCB+ and SCB-groups had similar lung function over time, but the SCB+ group had significantly worse SGRQ scores.

conclusionsSevere chronic bronchitis is associated with worse survival, shorter time to hospitalization, and worse health-related quality of life.

Indexed as

HospitalizationAgedBronchitis, ChronicCase-Control StudiesCohort StudiesFemaleHealth StatusHumansMaleMiddle AgedPulmonary EmphysemaQuality of LifeRespiratory Function TestsSurveys and QuestionnairesSurvival RateTime Factors

Identifiers

PMID23978192
PMCPMC12952910
OpenAlexW1994027941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.